Emily Clay

Emily Clay is a dedicated professional in the clinical research field, currently serving as Senior Manager and Clinical Project Lead at Alexion Pharmaceuticals, Inc. since March 2021. Previously, Clay held multiple roles in clinical trial management and research at Boston Children's Hospital, focusing on cardiovascular and critical care research initiatives, alongside ensuring compliance with Human Subject Research regulations. Early experience includes contributions as an Undergraduate Research Assistant at Bucknell University, measuring oxidative stress in quail species, and as a Clinical Research Intern at Dana-Farber Cancer Institute, where data management supported cancer risk prediction models. Emily Clay holds a degree from Bucknell University, which was earned in 2019.